The positive rates of S100A8 and S100A9 in tumor cells were 54.8% and 69.1% in the CRC tissues, compared to 7.1% and 16.7% in the matching distal normal tissues respectively (Table 2, p<0.001). This evidence concerns the gene S100A8 and neoplasm.